Trial intelligence / Profile preview

VIP: Adalimumab vs Phototherapy in Psoriasis

NCT01553058Phase 4Completed

Sponsor
University of Pennsylvania
Start
Jul 2012
Primary completion
Aug 2016
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of adalimumab in psoriasis, sponsored by University of Pennsylvania. Started Jul 2012; status: completed.

02

Drugs

03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT01553058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01553058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call